Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Deloitte
Daiichi Sankyo
Cantor Fitzgerald
Boehringer Ingelheim
Healthtrust
US Department of Justice
US Army
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050717

« Back to Dashboard

NDA 050717 describes MONUROL, which is a drug marketed by Zambon Spa and is included in one NDA. It is available from one supplier. Additional details are available on the MONUROL profile page.

The generic ingredient in MONUROL is fosfomycin tromethamine. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fosfomycin tromethamine profile page.
Summary for 050717
Tradename:MONUROL
Applicant:Zambon Spa
Ingredient:fosfomycin tromethamine
Patents:0
Therapeutic Class:Antibacterials
Medical Subject Heading (MeSH) Categories for 050717
Suppliers and Packaging for NDA: 050717
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MONUROL fosfomycin tromethamine FOR SUSPENSION;ORAL 050717 NDA Allergan, Inc. 0456-4300 0456-4300-08 1 POWDER in 1 PACKET (0456-4300-08)
MONUROL fosfomycin tromethamine FOR SUSPENSION;ORAL 050717 NDA Allergan, Inc. 0456-4300 0456-4300-01 1 DOSE PACK in 1 CARTON (0456-4300-01) > 1 POWDER in 1 DOSE PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrengthEQ 3GM BASE/PACKET
Approval Date:Dec 19, 1996TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
AstraZeneca
Chubb
Fuji
Argus Health
QuintilesIMS
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot